Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial
Abstract Background Mild cognitive impairment (MCI) is a transitional state between normal ageing and dementia. Most MCI patients will progress to dementia within 5 years; therefore, early intervention for MCI is important for delaying the occurrence and progression of dementia. Yi Shen Fang (YSF) g...
Saved in:
Main Authors: | Zhongwei Sha (Author), Zhenghao Zhao (Author), Nana Li (Author), Shuyun Xiao (Author), Ou Li (Author), Jie Zhang (Author), Zhimin Li (Author), Jian Xu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental verification about treatment of Bu-Shen-Yi-Jing-Fang in Alzheimer's disease by the analysis of the feasible signaling pathway of network pharmacology
by: Yingchao Hu, et al.
Published: (2024) -
Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway
by: Zhuojing Tan, et al.
Published: (2022) -
Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes
by: Mingzhu Liang, et al.
Published: (2022) -
Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
by: Xinhui Liu, et al.
Published: (2018) -
Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial-Mesenchymal Transition
by: Yuan Zhao, et al.
Published: (2022)